myelin-basic-protein and Hematoma

myelin-basic-protein has been researched along with Hematoma* in 5 studies

Other Studies

5 other study(ies) available for myelin-basic-protein and Hematoma

ArticleYear
Effects of minimally invasive puncture and drainage of intracranial hematoma on the blood-brain barrier in patients with cerebral hemorrhage.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2007, Volume: 27, Issue:1

    The effects of minimally invasive surgery on the blood-brain barrier (BBB) of 30 patients with cerebral hemorrhage were investigated. Difference of the BBB index and serum MBP concentration were assessed in 15 cases of conservative treatment group and 15 cases of minimally invasive surgery group. The BBB index in minimally invasive surgery group was significantly lower than in conservative treatment group (P<0.05), and the BBB index in the two treatment groups was significantly higher than in control group (P<0.01). Serum MBP concentration in minimally invasive surgery group was significantly lower than in conservative treatment group (P<0.05), and that in the two treatment groups was significantly higher than in control group (P<0.01). It was suggested the permeability of BBB in patients with cerebral hemorrhage was increased, and BBB index and serum MBP concentration in patients with cerebral hemorrhage were increased. Minimally invasive surgery can reduce the lesion of cytotoxicity to BBB and cerebral edema.

    Topics: Aged; Albumins; Biuret Reaction; Blood-Brain Barrier; Bromcresol Green; Case-Control Studies; Drainage; Enzyme-Linked Immunosorbent Assay; Female; Hematoma; Humans; Indicators and Reagents; Intracranial Hemorrhages; Male; Middle Aged; Myelin Basic Protein; Radiography; Spinal Puncture; Treatment Outcome; Urokinase-Type Plasminogen Activator

2007
Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions.
    Neuroreport, 1997, Dec-01, Volume: 8, Issue:17

    The expression of encephalitogenic peptide (EP), a 68-86 amino acid sequence of guinea pig myelin basic protein (MBP), was investigated in autopsied brains with focal cerebral damage or with diffuse white matter (WM) lesions. EP immunoreactive fibers were distributed in parallel with fibers immunoreactive for amyloid protein precursor (APP), an indicator of WM damages. EP was expressed in the periphery of cerebral infarctions and hematoma in the acute and subacute stages, but was also distributed in diffuse WM lesions due to heterogeneous causes. These data indicate that EP epitopes are exposed specifically in ongoing WM damages, and that the destruction of myelin occurs sporadically in diffuse WM lesions of varying intensity.

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Autopsy; Brain; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Dementia; Guinea Pigs; Hematoma; Humans; Myelin Basic Protein; Myelin Sheath; Nerve Fibers; Peptide Fragments

1997
[The value of serum myelin basic protein in assessment of severity of acute closed head trauma].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1995, Volume: 26, Issue:2

    Serum levels of myelin basic protein (MBP) were measured in 112 patients after acute head injury by enzyme linked immuno-absorbent assay (ELISA). Patients with cerebral concussion showed no significant change in serum MBP. Patients with cerebral contusion, extradural hematoma or intracerebral hematoma had a mean serum MBP concentration much higher than that of patients with cerebral concussion. And patients with extradural hematoma had a mean serum MBP concentration much lower than that of patients with cerebral contusion and intracerebral hematoma; the differences were significant (P < 0.05). But there was no significant difference between patients with cerebral contusion and intracerebral hematoma (P > 0.05). The amount of serum MBP was significantly correlated with the volume of extradural hematoma, intracerebral hematoma and with the extent of the cerebral contusion (P < 0.05). This study suggested that the serum MBP may reflect the type and severity of closed head injury patients.

    Topics: Adolescent; Adult; Aged; Brain Concussion; Cerebral Hemorrhage; Child; Enzyme-Linked Immunosorbent Assay; Female; Hematoma; Humans; Male; Middle Aged; Myelin Basic Protein; Trauma Severity Indices

1995
Increase in myelin basic protein in CSF after brain surgery.
    Journal of neurology, 1980, Volume: 223, Issue:4

    Myelin basic protein in spinal fluid was measured with a radioimmunoassay method after surgery of brain tumors and posttraumatic brains in thirteen cases. Three cases were studied daily for up to three weeks. Immediately after the operation the values were high but then successively returned to normal. Repeated measurement of the myelin basic protein in spinal fluid seem to be useful for assessing the healing rate of brain tissue after surgery for brain tumors and after other brain damage.

    Topics: Adult; Aged; Brain Diseases; Brain Neoplasms; Contusions; Ependymoma; Female; Glioma; Hematoma; Humans; Male; Meningioma; Middle Aged; Myelin Basic Protein; Postoperative Period; Skull Fractures

1980
Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury.
    Lancet (London, England), 1978, Jan-21, Volume: 1, Issue:8056

    Serum levels of myelin basic protein (M.B.P.), a nervous-system-specific protein, were measured in 157 patients after head injury and related both to the type of brain damage and to the clinical outcome assessed three months after injury. Mean concentrations of M.B.P. in patients with severe intracerebral damage, with or without associated extracerebral haematoma, were significantly raised at the time of admission and remained high for two weeks after injury. In patients with extracerebral haematoma not associated with severe intracerebral damage mean M.B.P. values rose four to six days after injury and were significantly raised only in patients with poor eventual outcome. Mean serum-M.B.P. concentrations in patients with a good outcome after injury were similar to those in controls. In patients with a poor outcome the mean M.B.P. levels between two and six days after injury were significantly higher than in those with a good outcome. The assay of serum-M.B.P. may be valuable in assessment of severity of brain damage in patients after head injury and in prediction of outcome.

    Topics: Blood-Brain Barrier; Brain Diseases; Brain Injuries; Brain Neoplasms; Cerebrovascular Disorders; Craniocerebral Trauma; Hematoma; Humans; Myelin Basic Protein; Prognosis

1978